作者: Dan G. Duda , Rebecca S. Heist , Dushyant V. Sahani , Triantafyllos Stylianopoulos , Jeffrey A. Engelman
关键词:
摘要: We thank Ciccolini et al. (1) for their interest in our report (2) on a clinical study, published recently PNAS. In that paper, we improved tumor vascular function after anti-VEGF therapy with carboplatin and nab-paclitaxel associates survival non-small cell lung cancer (NSCLC) patients. also suggest imaging circulating markers of normalization could be useful biomarkers response to bevacizumab-based therapies … [↵][1]1To whom correspondence should addressed. Email: jain{at}steele.mgh.harvard.edu. [1]: #xref-corresp-1-1